References
[1] Glauber M, Miceli A. State of the art for approaching the mitral
valve: sternotomy, minimally invasive or total endoscopic robotic? Eur J
Cardiothorac Surg 2015;48:639–41. doi:10.1093/ejcts/ezv312.
[2] Modi P, Hassan A, Chitwood WR. Minimally invasive mitral valve
surgery: a systematic review and meta-analysis. Eur J Cardiothorac Surg
2008;34:943–52. doi:10.1016/j.ejcts.2008.07.057.
[3] Cheng DCH, Martin J, Lal A, Diegeler A, Folliguet TA, Nifong LW,
et al. Minimally invasive versus conventional open mitral valve surgery:
a meta-analysis and systematic review. Innovations (Phila)
2011;6:84–103. doi:10.1097/IMI.0b013e3182167feb.
[4] Raanani E, Spiegelstein D, Sternik L, Preisman S, Moshkovitz Y,
Smolinsky AK, et al. Quality of mitral valve repair: median sternotomy
versus port-access approach. J Thorac Cardiovasc Surg 2010;140:86–90.
doi:10.1016/j.jtcvs.2009.09.035.
[5] Iribarne A, Russo MJ, Easterwood R, Hong KN, Yang J, Cheema FH,
et al. Minimally invasive versus sternotomy approach for mitral valve
surgery: a propensity analysis. Ann Thorac Surg
2010;90:1471–7–discussion1477–8.
doi:10.1016/j.athoracsur.2010.06.034.
[6] Goldstone AB, Atluri P, Szeto WY, Trubelja A, Howard JL,
MacArthur JW, et al. Minimally invasive approach provides at least
equivalent results for surgical correction of mitral regurgitation: a
propensity-matched comparison. J Thorac Cardiovasc Surg
2013;145:748–56. doi:10.1016/j.jtcvs.2012.09.093.
[7] McClure RS, Athanasopoulos LV, McGurk S, Davidson MJ, Couper GS,
Cohn LH. One thousand minimally invasive mitral valve operations: early
outcomes, late outcomes, and echocardiographic follow-up. J Thorac
Cardiovasc Surg 2013;145:1199–206. doi:10.1016/j.jtcvs.2012.12.070.
[8] Murzi M, Cerillo AG, Miceli A, Bevilacqua S, Kallushi E, Farneti
P, et al. Antegrade and retrograde arterial perfusion strategy in
minimally invasive mitral-valve surgery: a propensity score analysis on
1280 patients. Eur J Cardiothorac Surg 2013;43:e167–72.
doi:10.1093/ejcts/ezt043.
[9] Yoo JS, Kim JB, Jung S-H, Choo SJ, Chung CH, Lee JW.
Echocardiographic assessment of mitral durability in the late period
following mitral valve repair: minithoracotomy versus conventional
sternotomy. J Thorac Cardiovasc Surg 2014;147:1547–52.
doi:10.1016/j.jtcvs.2013.05.042.
[10] Glauber M, Miceli A, Canarutto D, Lio A, Murzi M, Gilmanov D,
et al. Early and long-term outcomes of minimally invasive mitral valve
surgery through right minithoracotomy: a 10-year experience in 1604
patients. J Cardiothorac Surg 2015;10:181.
doi:10.1186/s13019-015-0390-y.
[11] Atluri P, Stetson RL, Hung G, Gaffey AC, Szeto WY, Acker MA, et
al. Minimally invasive mitral valve surgery is associated with
equivalent cost and shorter hospital stay when compared with traditional
sternotomy. J Thorac Cardiovasc Surg 2016;151:385–8.
doi:10.1016/j.jtcvs.2015.08.106.
[12] Lange R, Voss B, Kehl V, Mazzitelli D, Tassani-Prell P, Günther
T. Right Minithoracotomy Versus Full Sternotomy for Mitral Valve Repair:
A Propensity Matched Comparison. Ann Thorac Surg 2017;103:573–9.
doi:10.1016/j.athoracsur.2016.06.055.
[13] Akins CW, Miller DC, Turina MI, Kouchoukos NT, Blackstone EH,
Grunkemeier GL, et al. Guidelines for reporting mortality and morbidity
after cardiac valve interventions. Ann Thorac Surg 2008;85:1490–5.
doi:10.1016/j.athoracsur.2007.12.082.
[14] Tatum JM, Bowdish ME, Mack WJ, Quinn AM, Cohen RG, Hackmann AE,
et al. Outcomes after mitral valve repair: A single-center 16-year
experience. J Thorac Cardiovasc Surg 2017.
doi:10.1016/j.jtcvs.2017.01.047.
[15] Fine JP, Gray RJ. A Proportional Hazards Model for the
Subdistribution of a Competing Risk. Journal of the American Statistical
Association 2012.
doi:10.1080/01621459.1999.10474144;page:string:Article/Chapter.
[16] Gray RJ. A class of K-sample tests for comparing the cumulative
incidence of a competing risk. The Annals of Statistics 1988.
doi:10.2307/2241622.
[17] Coutinho GF, Antunes MJ. Mitral valve repair for degenerative
mitral valve disease: surgical approach, patient selection and long-term
outcomes. Heart 2017:heartjnl–2016–311031.
doi:10.1136/heartjnl-2016-311031.
[18] Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP,
Fleisher LA, et al. 2017 AHA/ACC Focused Update of the 2014 AHA/ACC
Guideline for the Management of Patients With Valvular Heart Disease: A
Report of the American College of Cardiology/American Heart Association
Task Force on Clinical Practice Guidelines. Circulation
2017:CIR.0000000000000503. doi:10.1161/CIR.0000000000000503.
[19] David TE, Armstrong S, McCrindle BW, Manlhiot C. Late outcomes
of mitral valve repair for mitral regurgitation due to degenerative
disease. Circulation 2013;127:1485–92.
doi:10.1161/CIRCULATIONAHA.112.000699.
[20] DiBardino DJ, ElBardissi AW, McClure RS, Razo-Vasquez OA, Kelly
NE, Cohn LH. Four decades of experience with mitral valve repair:
analysis of differential indications, technical evolution, and long-term
outcome. J Thorac Cardiovasc Surg 2010;139:76–83–discussion83–4.
doi:10.1016/j.jtcvs.2009.08.058.
[21] Suri RM, Clavel M-A, Schaff HV, Michelena HI, Huebner M,
Nishimura RA, et al. Effect of Recurrent Mitral Regurgitation Following
Degenerative Mitral Valve Repair: Long-Term Analysis of Competing
Outcomes. J Am Coll Cardiol 2016;67:488–98.
doi:10.1016/j.jacc.2015.10.098.